Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

AMDA / Amedica Corporation

2018-02-15 sec.gov
  As filed with the Securities and Exchange Commission on February 14, 2018 Registration No. 333-______       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933       Amedica Corporation (Exact name of registrant as specified in its charter)       Delaware   3841   84-1375299 (State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classification Code Number)   (IRS Em

AMDA / Amedica Corporation AM

2018-02-05 sec.gov
  As filed with the Securities and Exchange Commission on February 2, 2018 Registration No. 333-211520       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933       Amedica Corporation (Exact name of registrant as specified in its charter)     Delaware   3841   84-1375299 (State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classi

AMDA / Amedica Corporation (Current Report)

2018-02-01 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of report (Date of earliest event reported): January 31, 2018   Amedica Corporation (Exact name of registrant as specified in its charter)   Delaware   001-33624   84-1375299 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.

AMDA / Amedica Corporation AM

2018-01-19 sec.gov
  As filed with the Securities and Exchange Commission on January 19, 2018 Registration No. 333-211520       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933     Amedica Corporation (Exact name of registrant as specified in its charter)     Delaware   3841   84-1375299 (State or other jurisdiction of incorporation or organization)   (Primary Standard Industrial Classifica

Sundance Strategies, Inc. Announces New CFO

2018-01-11 accesswire
PROVO, UT / ACCESSWIRE / January 11, 2018 / Sundance Strategies, Inc. (OTC PINK: SUND), an innovative company engaged in acquiring related insurance contracts, policies and obligations into secure, reinsured Net Insurance Benefits known as (NIBs), today announces the appointment of Karl Farnsworth as Chief Financial Officer. (59-2)

AMDA / Amedica Corporation - Stock Institutional Ownership and Shareholders - Fintel.io

2018-01-08 fintel.io
Amedica Corporation (NASDAQ:AMDA) has 15 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,920,569 shares. Largest shareholders include Renaissance Technologies LLC, Vanguard Group Inc, Geode Capital Management, Llc, BlackRock Inc., Two Sigma Securities, Llc, Virtu Financial LLC, Bank of New York Mellon Corp, Kcg Holdings, Inc. (61-5)

AMDA / Amedica Corporation / Sabby Management, LLC - SABBY 13G-A AMDA 1.08.18 (Passive Investment)

2018-01-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Amedica Corporation (Name of Issuer) Common Shares (Title of Class of Securities) 023435407 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of thi

AMDA / Amedica Corporation / Sabby Management, LLC - SABBY 13G-A AMDA 1.08.18 (Passive Investment)

2018-01-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Amedica Corporation (Name of Issuer) Common Shares (Title of Class of Securities) 023435407 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of thi

AMDA / Amedica Corporation (Current Report)

2018-01-04 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 3, 2018   Amedica Corporation (Exact name of registrant as specified in its charter)   Delaware   001-33624   84-1375299 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.

AMDA / Amedica Corporation /A (Quarterly Report)

2017-12-29 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 10-Q/A (Amendment No. 1)       (Mark One)   [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended June 30, 2017   OR   [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number 001-33624       Amedica Corporation (Exact name of registrant as specified in its charter)       DELAW

AMDA / Amedica Corporation /A (Quarterly Report)

2017-12-29 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 10-Q/A (Amendment No. 2)       (Mark One)   [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended September 30, 2017   OR   [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number 001-33624       Amedica Corporation (Exact name of registrant as specified in its charter)      

AMDA / Amedica Corporation /A (Quarterly Report)

2017-12-29 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 10-Q/A (Amendment No. 1)       (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended March 31, 2017   OR   [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number 001-33624       Amedica Corporation (Exact name of registrant as specified in its charter)       DELAWA

AMDA / Amedica Corporation /A (Quarterly Report)

2017-12-27 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 10-Q/A (Amendment No. 2)       (Mark One)   [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended September 30, 2016   OR   [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number 001-33624       Amedica Corporation (Exact name of registrant as specified in its charter)      

AMDA / Amedica Corporation /A (Annual Report)

2017-12-27 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549       FORM 10-K/A (Amendment No. 2)       [X] Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934   For the fiscal year ended December 31, 2016   or   [  ] Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934   For the transition period from _______ to _________   Commission File No.

AMDA / Amedica Corporation /A (Annual Report)

2017-12-12 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549       FORM 10-K/A (Amendment No. 1)       [X] Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934   For the fiscal year ended December 31, 2016   or   [  ] Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934   For the transition period from _______ to _________   Commission File No.


AMDA : Amedica Corporation Stock Analysis and Research Report

Amedica Corporation is a materials company focused on developing, manufacturing and selling silicon nitride ceramics that are used in medical implants and in a variety of industrial devices. At present, the company commercialize silicon nitride in the spine implant market. The company believe that its silicon nitride manufacturing expertise positions it favorably to introduce new and innovative devices in the medical and non- medical fields. The company also believe that Amedica is the first and only company to commercialize silicon nitride medical implants.

Amedica has received 510(k) regulatory clearance in the United States, a CE mark in Europe, and ANVISA approval in Brazil for a number of its devices that are designed for spinal fusion surgery. To date, more than 28,000 of its silicon nitride devices have been implanted into patients, with an 8-year successful track record. The company intend to file an FDA 510(k) submission for clearance in the United States of a novel compos...

Click for full article
CUSIP: 023435100